This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Warrior, U. Articles by Trevillyan, J. M. Search for Related Content PubMed PubMed Citation Articles by Warrior, U. Articles by Trevillyan, J. M. Social Bookmarking                         What's this?

Development of a p38 Kinase Binding Assay for High Throughput Screening

Abbott Laboratories, Abbott Park, IL

X. Grace Chiou

Abbott Laboratories, Abbott Park, IL

Michael P. Sheets

Pharmacia-Upjohn, Kalamazoo, MI

Richard J. Sciotti

Abbott Laboratories, Abbott Park, IL

Janet M. Parry

Abbott Laboratories, Abbott Park, IL

Robert L. Simmer

Abbott Laboratories, Abbott Park, IL

Bruce W. Surber

Abbott Laboratories, Abbott Park, IL

David J. Burns

Abbott Laboratories, Abbott Park, IL

Bruce A. Beutel

Abbott Laboratories, Abbott Park, IL

Karl W. Mollison

Abbott Laboratories, Abbott Park, IL

Stevan W. Djuric

Abbott Laboratories, Abbott Park, IL

James M. Trevillyan

Abbott Laboratories, Abbott Park, IL

p38 is a member of the mitogen-activated protein kinase (MAPK) family of serine/threonine kinases, which is activated by cellular stressors and has been shown to be a critical enzyme in the synthesis and action of proinflammatory cytokines, tumor necrosis factor- (TNF-) and interleukin-1ß (IL-1ß). A group of pyridinyl imidazole compounds such as SB202190 have been identified as selective inhibitors of p38 that bind directly to the ATP pocket of the enzyme. These compounds inhibit the p38 kinase activity, block TNF- and IL-1ß secretion both in vivo and in vitro and are found to be effective in animal models of arthritis, bone resorption, and endotoxin shock. We postulated that other classes of compounds capable of competing the binding of pyridinyl imidazole with p38 enzyme could have efficacy in the treatment of inflammatory diseases. Therefore, a simple and robust assay was developed to measure the ability of small molecules to inhibit the binding of tritium-labeled pyridinyl imidazole, SB202190, to recombinant p38 kinase. For assay development, the human p38 gene was cloned in baculovirus and then expressed in insect cells. Tritiated SB202190 was synthesized and used as the p38 ligand for a competitive filter binding assay. This assay has been used successfully to screen both synthetic and combinatorial chemical libraries for other classes of p38 kinase inhibitors.

Journal of Biomolecular Screening, Vol. 4, No. 3, 129-135 (1999)
DOI: 10.1177/108705719900400306


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. A. Kashem, R. M. Nelson, J. D. Yingling, S. S. Pullen, A. S. Prokopowicz III, J. W. Jones, J. P. Wolak, G. R. Rogers, M. M. Morelock, R. J. Snow, et al. Three Mechanistically Distinct Kinase Assays Compared: Measurement of Intrinsic ATPase Activity Identified the Most Comprehensive Set of ITK Inhibitors J Biomol Screen, February 1, 2007; 12(1): 70 - 83. [Abstract] [PDF]

				C. L. Hubert, S. E. Sherling, P. A. Johnston, and L. F. Stancato Data Concordance from a Comparison between Filter Binding and Fluorescence Polarization Assay Formats for Identification of ROCK-II Inhibitors J Biomol Screen, August 1, 2003; 8(4): 399 - 409. [Abstract] [PDF]